Article Details

Lack of Targeted Therapies for NRG1 Fusion-Positive Advanced Solid Tumors Comes to Attention

Retrieved on: 2020-10-22 20:00:00

Tags for this article:

Click the tags to see associated articles and topics

Lack of Targeted Therapies for NRG1 Fusion-Positive Advanced Solid Tumors Comes to Attention. View article details on hiswai:

Excerpt

<div>Therefore, NRG1 fusion can be treated with HER2/HER3 inhibitory <b>monoclonal</b> <b>antibodies</b> (mAbs), antibody-drug conjugates, EGFR tyrosine kinase ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up